WallStreetZenWallStreetZen

NASDAQ: ANIP
Ani Pharmaceuticals Inc Stock Ownership - Who owns Ani Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Ani Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Meredith CookSR. VP GENERAL COUNSEL SEC.2025-06-13400$61.37
$24.55kSell
Ori GutwergSVP GENERICS2025-05-15881$60.07
$52.92kSell
Christopher MutzHEAD OF RARE DISEASE2025-05-144,000$60.45
$241.80kSell
Meredith CookSR. VP GENERAL COUNSEL SEC.2025-05-13400$62.20
$24.88kSell
Muthusamy ShanmugamHEAD OF RD COO-NOVITIUM OPS2025-05-09700$76.83
$53.78kSell
Meredith CookSR. VP GENERAL COUNSEL SEC.2025-04-14400$68.96
$27.58kSell
Nikhil LalwaniPRESIDENT CEO2025-03-2317,455$64.26
$1.12MSell
Stephen P. CareySVP CFO2025-03-236,210$64.26
$399.05kSell
Krista DavisSVP CHIEF HR OFFICER2025-03-191,866$65.00
$121.29kSell
Meredith CookSR. VP GENERAL COUNSEL SEC.2025-03-13400$63.33
$25.33kSell

1 of 6

ANIP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANIP insiders and whales buy or sell their stock.

ANIP Shareholders

What type of owners hold Ani Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Meridian Venture Partners II LP86.50%18,737,728$1.24BInsider
Robert E. Brown Jr.78.33%16,967,490$1.12BInsider
Ross J. Mangano26.74%5,792,084$382.86MInsider
Blackrock Inc12.22%2,646,630$174.94MInstitution
Tracy Marshbanks10.66%2,308,568$152.60MInsider
Vanguard Group Inc5.45%1,181,471$78.10MInstitution
Victor A. Morgenstern4.32%936,014$61.87MInsider
Millennium Management LLC3.78%818,341$54.09MInstitution
Global Alpha Capital Management Ltd3.40%735,590$48.62MInstitution
Muthusamy Shanmugam3.39%734,508$48.55MInsider

1 of 3

ANIP vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANIP29.20%70.80%Net SellingNet Selling
EVO5.12%0.00%
HROW28.43%71.57%Net SellingNet Selling
DVAX65.36%34.64%Net Selling
PAHC44.43%55.57%Net Buying
View Top Pharmaceutical Stocks

Ani Pharmaceuticals Stock Ownership FAQ

Who owns Ani Pharmaceuticals?

Ani Pharmaceuticals (NASDAQ: ANIP) is owned by 92.20% institutional shareholders, 223.53% Ani Pharmaceuticals insiders, and 0.00% retail investors. Meridian Venture Partners II LP is the largest individual Ani Pharmaceuticals shareholder, owning 18.74M shares representing 86.50% of the company. Meridian Venture Partners II LP's Ani Pharmaceuticals shares are currently valued at $1.22B.

If you're new to stock investing, here's how to buy Ani Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.